menu
    • menu

    Company profile for Noramco

    Noramco-PSE
    News
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Normaco

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    pipeline-prospector-blog/pipeline-prospector-sept-2024-bms-wins-landmark-fda-approval-for-schizophrenia-med-sanofi-s-dupixent-okayed-for-copd

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    Related CompaniesRelated Companies

    About

    Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and manufacturing, Noramco offers services like supply-chain integration for high-purity controlled substances, efficient routes to APIs, analytical data, stability studies, regulatory help, formulation-friendly particle size grades, extended technical packages, DEA-compliant security and production capacity from kilos to multi-ton supply. Noramco also offers world-class supply security for controlled substances, from Schedule I to Schedule III.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NoramcoUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Swedes Landing Rd, Wilmington, DE 19801
    Telephone
    Telephone
    +1 3026523840
    Client Email
    Email
    aambrosi@Noramco.com
    Client Website
    Website
    https://www.noramco.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/noramco-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    cphi-worldwide-milan-70313.png

    CPhI Worldwide, Milan

    Attending

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-87243.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-64446.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DMF Submitted for Lisdexamfetamine Dimesylate API

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1638594073.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Small Volume Manufacture of APIs 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1582542575.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Reference Standards List 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1582615883.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Diversifying the Supply of Raw Materials
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    https://www.noramco.com/2024/06/12/diversifying-the-supply-of-raw-materials/

    PRESS RELEASE
    12 Jun 2024
    Share Share
    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group
    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    https://www.noramco.com/2024/03/14/noramco-announces-strategic-alignment-with-purisys-and-halo-pharma/

    PRESS RELEASE
    15 Mar 2024
    Share Share
    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    https://www.noramco.com/2023/11/02/noramco-announces-the-acquisition-of-the-cambrex-drug-product-business-unit/

    PRESS RELEASE
    02 Nov 2023
    Share Share
    Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
    Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

    01 Nov 2022

    // PRESS RELEASE

    https://www.noramco.com/2022/11/01/noramco-announces-submission-and-reactivation-of-the-drug-master-file-for-active-pharmaceutical-ingredient-methylnaltrexone-bromide/

    PRESS RELEASE
    01 Nov 2022
    Share Share
    Noramco Celebrates Diversity and International Women’s Day
    Noramco Celebrates Diversity and International Women’s Day

    07 Mar 2022

    // Randolph Ramirez PRESS RELEASE

    https://www.noramco.com/2022/03/07/noramco-celebrates-diversity-and-international-womens-day/

    Randolph Ramirez PRESS RELEASE
    07 Mar 2022
    Share Share
    Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate
    Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate

    03 Dec 2021

    // PRESS RELEASE

    https://www.noramco.com/2021/12/03/noramco-lisdexamfetamine-dmf-submission/

    PRESS RELEASE
    03 Dec 2021
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    REF. STANDARDS & IMPURITIES

    Check the ref. standards & impurities from this company

    Others

    read-more
    read-more

    01

    Amphetamine Formamide (NC)

    U.S.A
    CPhI Worldwide, Milan
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    Noramco

    CAS Number : 22148-75-0

    Details : N-formylamphetamine

    Monograph : 51634-2040

    Quantity Per Vial :

    Sale Unit :

    Price :

    Storage :

    Code/Batch No :

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    02

    8-Tetrahydrocannabinol (CI)

    U.S.A
    CPhI Worldwide, Milan
    Attending
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    Noramco

    CAS Number : 5957-75-5

    Details : USP Impurity

    Monograph : 51634-2161

    Quantity Per Vial :

    Sale Unit :

    Price :

    Storage :

    Code/Batch No :

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    03

    Amphetamine Sul